{"transactions":[{"id":2404466,"issuer":{"id":116059,"kind":"organization","name":"Axcella Health Inc.","symbol":"AXLA"},"owners":[{"id":130640,"kind":"person","name":"Schecter Alison D.","position":1,"cik":"0001782448","reported_name":"Schecter Alison D.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President - Research & Dev."}}],"security":"Stock Option (Right to Buy)","published_at":"2022-02-10T18:07:03.000Z","date":"2022-02-08","kind":"grant","acquired":true,"shares":56000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of this option shall vest and become exercisable on February 8, 2023, with the remainder vesting in 12 equal quarterly installments thereafter, subject to the Reporting Person's continued service on each such vesting date."}],"balance_after":56000,"derivative":{"exercise_price":1.63,"expiration_date":"2032-02-07","underlying":"Common Stock","underlying_shares":56000},"source":{"system":"sec-edgar","filing":"0001104659-22-019555","document":"tm226270-2_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1782448/000110465922019555/tm226270-2_4seq1.xml","form_type":"4"}},{"id":2473594,"issuer":{"id":116059,"kind":"organization","name":"Axcella Health Inc.","symbol":"AXLA"},"owners":[{"id":130640,"kind":"person","name":"Schecter Alison D.","position":1,"cik":"0001782448","reported_name":"Schecter Alison D.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President - Research & Dev."}}],"security":"Stock Option (Right to Buy)","published_at":"2021-12-14T17:21:11.000Z","date":"2021-12-10","kind":"grant","acquired":true,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On March 17, 2021, the Reporting Person was granted an option to purchase 75,000 shares of AXLA common stock, which vest in three equal installments subject to the satisfaction of certain performance criteria. On December 10, 2021, the Issuer's Compensation Committee confirmed that the performance criteria had been met with regards to one installment, resulting in the vesting of 25,000 shares."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"On March 17, 2021, the Reporting Person was granted an option to purchase 75,000 shares of AXLA common stock, which vest in three equal installments subject to the satisfaction of certain performance criteria. On December 10, 2021, the Issuer's Compensation Committee confirmed that the performance criteria had been met with regards to one installment, resulting in the vesting of 25,000 shares."}],"balance_after":25000,"derivative":{"exercise_price":5.57,"expiration_date":"2031-03-17","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001104659-21-149610","document":"tm2135411-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1782448/000110465921149610/tm2135411-1_4seq1.xml","form_type":"4"}},{"id":2779498,"issuer":{"id":116059,"kind":"organization","name":"Axcella Health Inc.","symbol":"AXLA"},"owners":[{"id":130640,"kind":"person","name":"Schecter Alison D.","position":1,"cik":"0001782448","reported_name":"Schecter Alison D.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President - Research & Dev."}}],"security":"Stock Option (Right to Buy)","published_at":"2021-03-18T21:27:42.000Z","date":"2021-03-17","kind":"grant","acquired":true,"shares":250000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of this option shall vest and become exercisable on March 15, 2022, with the remainder vesting in 12 equal quarterly installments thereafter."}],"balance_after":250000,"derivative":{"exercise_price":5.57,"expiration_date":"2031-03-16","underlying":"Common Stock","underlying_shares":250000},"source":{"system":"sec-edgar","filing":"0001104659-21-038587","document":"tm2110273-2_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1782448/000110465921038587/tm2110273-2_4seq1.xml","form_type":"4"}},{"id":3318736,"issuer":{"id":6015,"kind":"organization","name":"Cartesian Therapeutics, Inc."},"owners":[{"id":130640,"kind":"person","name":"Schecter Alison D.","position":1,"cik":"0001782448","reported_name":"Schecter Alison D.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2020-01-06T20:08:37.000Z","date":"2020-01-02","kind":"grant","acquired":true,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option will vest as to 25% on January 2, 2021. The remainder of the underlying shares will vest in 36 equal monthly installments thereafter."}],"balance_after":100000,"derivative":{"exercise_price":2.3,"expiration_date":"2030-01-01","underlying":"Common Stock","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0001453687-20-000014","document":"wf-form4_157835929977150.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1782448/000145368720000014/wf-form4_157835929977150.xml","form_type":"4"}},{"id":3460085,"issuer":{"id":6015,"kind":"organization","name":"Cartesian Therapeutics, Inc."},"owners":[{"id":130640,"kind":"person","name":"Schecter Alison D.","position":1,"cik":"0001782448","reported_name":"Schecter Alison D.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2019-07-17T16:18:10.000Z","date":"2019-07-15","kind":"grant","acquired":true,"shares":350000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option vests as to 25% on July 15, 2020, and the remainder of the underlying shares will vest in 36 equal monthly installments thereafter."}],"balance_after":350000,"derivative":{"exercise_price":1.71,"expiration_date":"2029-07-14","underlying":"Common Stock","underlying_shares":350000},"source":{"system":"sec-edgar","filing":"0001453687-19-000082","document":"wf-form4_156339467597510.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1782448/000145368719000082/wf-form4_156339467597510.xml","form_type":"4"}}]}